| Yowie Group Ltd (YOW) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Dec 24 - Half Year Accounts
|
27 Feb 2026 9:56AM |
$0.014 |
$0.014 |
fallen by
0%
|
|
| Vulcan Steel Limited (VSL) ORDINARY FULLY PAID |
Materials |
$857 |
Update - Dividend/Distribution - VSL
|
27 Feb 2026 9:56AM |
$6.490 |
$5.850 |
fallen by
9.86%
|
|
| 5G Networks Limited (5GN) ORDINARY FULLY PAID |
Information Technology |
$17 |
Half Year Results Presentation
|
27 Feb 2026 9:56AM |
$0.099 |
$0.064 |
fallen by
35.35%
|
|
5GN - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue growth of 36.5% to $36.2 million.
- EBITDA increased to $1.3 million, reflecting a 34.1% YoY growth.
- Gross profit margin improved to 52%.
- AUCyber Limited contributed $10.4 million in revenue.
- Cash balance decreased by $11.5 million due to growth initiatives.
- $4.2 million returned via on-market share buyback.
- Strategic review of AUCyber integration and potential full acquisition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resonance Health Limited (RHT) ORDINARY FULLY PAID |
Health Care |
$28 |
Half Year Report & Accounts
|
27 Feb 2026 9:56AM |
$0.047 |
$0.058 |
risen by
23.40%
|
|
RHT - Price-sensitive ASX Announcement
Full Release
Key Points
- Half-year profit after tax was $1,466,049, marking a significant improvement from the previous year's loss.
- Sales revenue increased by 53% to $7,975,096, driven by clinical trial agreements and the integration of TrialsWest.
- The company's core business focuses on software-as-medical-device technologies for radiological image analysis.
- Research and development expenditure for the half-year was $601,617.
- No significant changes in the state of affairs occurred during the half-year.
- No dividends were declared for the current financial period.
- The financial report complies with Australian accounting standards and assumes going concern.
- The directors are confident in the company's ability to meet its debts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$44 |
Cleansing Statement - Section 708A(12C)(e)
|
27 Feb 2026 9:56AM |
$0.100 |
$0.056 |
fallen by
44%
|
|
| AUCyber Limited (CYB) ORDINARY FULLY PAID |
Information Technology |
$9 |
Half Yearly Report and Accounts
|
27 Feb 2026 9:55AM |
$0.062 |
$0.041 |
fallen by
33.87%
|
|
CYB - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for the half-year was $9,256,714.
- Loss before tax was $2,422,416.
- Cash balance at the end of the period was $1,972,790.
- Total assets amounted to $12,082,446.
- Share capital remains at $135,840,073.
- Employee share options were issued as part of long-term incentives.
- Depreciation and amortization costs were significant.
- Equity totals $5,463,886.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Electro Optic Systems Holdings Limited (EOS) ORDINARY FULLY PAID |
Industrials |
$2,111 |
Notification of cessation of securities - EOS
|
27 Feb 2026 9:55AM |
$8.540 |
$9.520 |
risen by
11.48%
|
|
| 5G Networks Limited (5GN) ORDINARY FULLY PAID |
Information Technology |
$17 |
Half Yearly Report and Accounts
|
27 Feb 2026 9:55AM |
$0.099 |
$0.064 |
fallen by
35.35%
|
|
5GN - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss of $6.43 million compared to a profit of $6.33 million in the previous year.
- Revenue increased by 36.5% to $36.2 million.
- Strong demand for cybersecurity services with revenue contribution from AUCyber Limited.
- Employee benefits and cloud hosting costs increased significantly.
- Cash balance of $14 million at the end of the period.
- Completion of a share buyback program acquiring 30,095,039 shares for $4.2 million.
- No dividends declared during the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$277 |
Update on Strategic Review
|
27 Feb 2026 9:55AM |
$1.255 |
$1.075 |
fallen by
14.34%
|
|
| Wellnex Life Limited (WNX) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Wellnex Life Releases Half Year Report
|
27 Feb 2026 9:54AM |
$0.105 |
$0.082 |
fallen by
21.90%
|
|
WNX - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 8% to $12.9 million.
- Gross margin improved by 9.4 percentage points to 32.1%.
- Achieved operating breakeven in Q2 FY26.
- Focus on leaner operations and tighter capital management.
- Exploring funding options for capital raising.
- Committed to delivering consistent performance in H2 FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$37 |
Imugene to Present at TD Cowen Annual Health Care Conference
|
27 Feb 2026 9:54AM |
$0.240 |
$0.069 |
fallen by
71.25%
|
|
| Fortifai Ltd (FTI) ORDINARY FULLY PAID |
Communication Services |
$276 |
Section 708A Notice - Share Issue
|
27 Feb 2026 9:54AM |
$0.465 |
$0.800 |
risen by
72.04%
|
|
| Wellnex Life Limited (WNX) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Half Yearly Report and Accounts
|
27 Feb 2026 9:54AM |
$0.105 |
$0.082 |
fallen by
21.90%
|
|
WNX - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss of $1.793 million for the half-year ending 31 December 2025.
- Operating cash outflows totaled $3.142 million.
- Current liabilities exceeded current assets by $4.252 million.
- No dividends paid during the period.
- Total equity stood at $10.044 million.
- Significant borrowings and related party loans detailed.
- Auditor's review affirmed compliance with accounting standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Austin Metals Limited (AYT) ORDINARY FULLY PAID |
Materials |
$5 |
Application for quotation of securities - AYT
|
27 Feb 2026 9:53AM |
$0.004 |
$0.003 |
fallen by
37.50%
|
|
| Fortifai Ltd (FTI) ORDINARY FULLY PAID |
Communication Services |
$276 |
Application for quotation of securities - FTI
|
27 Feb 2026 9:53AM |
$0.465 |
$0.800 |
risen by
72.04%
|
|
| Maggie Beer Holdings Ltd (MBH) ORDINARY FULLY PAID |
Consumer Staple |
$24 |
1HFY26 Results Presentation
|
27 Feb 2026 9:53AM |
$0.081 |
$0.053 |
fallen by
34.57%
|
|
MBH - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit from operations increased by 68% to $398K.
- Maggie Beer Products sales increased by 4.6%, while Hampers & Gifts Australia sales declined by 4.8%.
- Operational savings of $2.2 million achieved through cost-out programs.
- Cash position improved by $11.5 million with no debt.
- Strategic goals include revenue growth to $100m+, new product development, and expansion of channels.
- Ongoing strategic review of Hampers & Gifts Australia with potential merger, alliance, or sale options.
- Operational improvements include platform transition to Shopify and inventory control enhancements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| archTIS Limited (AR9) ORDINARY FULLY PAID |
Information Technology |
$21 |
Investor Presentation
|
27 Feb 2026 9:53AM |
$0.090 |
$0.044 |
fallen by
51.11%
|
|
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$2,577 |
Appendix 4E and 2025 full year accounts
|
27 Feb 2026 9:53AM |
$13.440 |
$20.330 |
risen by
51.26%
|
|
NEU - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit after tax for 2025 was A$30.4 million, compared to A$142.0 million in 2024.
- Basic earnings per share for 2025 were A$0.2373.
- Total revenue for 2025 was A$84.8 million, a 63% decrease from 2024.
- Royalty income increased by 15% to A$64.6 million.
- Corporate and administrative costs for 2025 were A$6.2 million.
- Cash and short-term investments at the end of 2025 were A$296.1 million.
- The company executed a A$39.6 million share buy-back.
- Financial statements received an unqualified audit opinion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bapcor Limited (BAP) ORDINARY FULLY PAID |
Consumer Discretionary |
$589 |
Reinstatement to Quotation
|
27 Feb 2026 9:53AM |
$1.715 |
$0.875 |
fallen by
48.98%
|
|
BAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Bapcor Limited's securities suspension lifted
- Reinstatement follows capital raising announcement
- ASX compliance related to institutional capital raising
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Terra Metals Limited (TM1) ORDINARY FULLY PAID |
Materials |
$232 |
Corporate Presentation
|
27 Feb 2026 9:52AM |
$0.405 |
$0.225 |
fallen by
44.44%
|
|
| Bapcor Limited (BAP) ORDINARY FULLY PAID |
Consumer Discretionary |
$589 |
Completion of Institutional Component of Equity Raising
|
27 Feb 2026 9:52AM |
$1.715 |
$0.875 |
fallen by
48.98%
|
|
BAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful completion of the institutional component of equity raising
- Total expected to raise approximately $200 million
- Institutional Entitlement Offer raised approximately $157 million
- Retail Entitlement Offer expected to raise a further $43 million
- New Shares to trade on the ASX from 6 March 2026
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Humm Group Limited (HUM) ORDINARY FULLY PAID |
Financials |
$217 |
TOV: HUM - Panel Accepts Undertaking Continues Proceedings
|
27 Feb 2026 9:52AM |
$0.665 |
$0.430 |
fallen by
35.34%
|
|
HUM - Price-sensitive ASX Announcement
Full Release
Key Points
- Humm Group Limited was involved in proceedings with the Australian Takeovers Panel concerning insider participation and conflicts of interest.
- The Panel accepted an undertaking from Humm which addressed these issues by forming an Independent Board Committee (IBC) excluding conflicted members.
- The undertaking requires Humm to appoint and include non-conflicted non-executive directors in the IBC to handle the Credit Corp Proposal.
- The CEO of Humm is to be appointed to the board as part of the undertaking.
- Humm is tasked with finding a new independent non-executive director to chair the IBC.
- Credit Corp Proposal involves acquiring control over Humm with conditions that raised concerns about conflicts of interest involving Mr. Abercrombie.
- No non-disclosure agreement had been signed with Credit Corp by February 2026, leading to ongoing procedural issues.
- The Panel emphasized that complex issues like insider participation require careful handling, focusing on substance over form.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clarity Pharmaceuticals Ltd (CU6) ORDINARY FULLY PAID |
Health Care |
$851 |
Half Year Accounts
|
27 Feb 2026 9:51AM |
$3.600 |
$2.280 |
fallen by
36.67%
|
|
| Kina Securities Limited (KSL) ORDINARY FULLY PAID |
Financials |
$350 |
FY25 Results Investor Presentation
|
27 Feb 2026 9:51AM |
$1.235 |
$1.190 |
fallen by
3.64%
|
|
KSL - Price-sensitive ASX Announcement
Full Release
Key Points
- Return on Equity increased to 17.4%.
- Total capital ratio at 17.1%, above regulatory threshold.
- Cost to Income Ratio improved to 54.7%.
- Final dividend increased by 22% to 19.3 toea.
- Earnings per share grew by 20% to 41.8 toea.
- Revenue rose by 13% to K545.5 million.
- Lending income increased by 22%.
- Loan book growth of 13%.
- Net interest margin improved with higher Treasury Bill yields.
- Non-interest revenue driven by FX and digital income.
- Operational costs increased by 4% due to strategic investments.
- Improvement in asset quality and capital adequacy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Swift TV Limited (STV) ORDINARY FULLY PAID |
Communication Services |
$10 |
Half Year Accounts and Appendix 4D
|
27 Feb 2026 9:51AM |
$0.011 |
$0.007 |
fallen by
36.36%
|
|
STV - Price-sensitive ASX Announcement
Full Release
Key Points
- Swift TV Limited reported a comprehensive loss of $536,000 for the half year.
- 86.2% of revenues were recurring, aiding financial stability amid reduced expenses.
- Cash position decreased to $1,780,000 due to investments in Swift TV development.
- Pre-orders for Swift TV devices reached over 4,300, with commercial release on track for Q3 2026.
- No dividends were declared during the reporting period.
- Strategic investment continues in sales, marketing, and product development for market expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
